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Abstract
AIM: To investigate endoscopic and clinicopathologic 
characteristics of early gastric cancer (EGC) according 
to microsatellite instability phenotype.
METHODS: �ata were retrospectively collected from 
a single tertiary referral center. Of 981 EGC patients 
surgically treated between �ecember 2003 and Oc-
tober 2007, 73 consecutive EGC patients with two or 
more microsatellite instability (�SI) mutation [high �SI 
(�SI-H)] and 146 consecutive EGC patients with one or 
no �SI mutation (non-�SI-H) were selected. The en-
doscopic and clinicopathologic features were compared 
between the �SI-H and non-�SI-H EGC groups.
RESULTS: In terms of endoscopic characteristics, �SI-H 
EGCs more frequently presented with elevated pattern 
(OR 4.38, 95% CI: 2.40-8.01, P  < 0.001), moderate-
to-severe atrophy in the surrounding mucosa (OR 1.91, 
95% CI: 1.05-3.47, P  = 0.033), antral location (OR 3.99, 
95% CI: 2.12-7.52, P  < 0.001) and synchronous le-
sions, compared to non-�SI-H EGCs (OR 2.65, 95% CI: 
1.16-6.07, P  = 0.021). Other significant clinicopatholog-
ic characteristics of �SI-H EGC included predominance 
of female sex (OR 2.77, 95% CI: 1.53-4.99, P  < 0.001), 
older age (> 70 years) (OR 3.30, 95% CI: 1.57-6.92, 
P  = 0.002), better histologic differentiation (OR 2.35, 
95% CI: 1.27-4.34, P  = 0.007), intestinal type by Lau-
ren classification (OR 2.34, 95% CI: 1.15-4.76, P  = 
0.019), absence of a signet ring cell component (OR 
2.44, 95% CI: 1.02-5.86, P  = 0.046), presence of mu-
cinous component (OR 5.06, 95% CI: 1.27-20.17, P  = 
0.022), moderate-to-severe lymphoid stromal reaction 
(OR 3.95, 95% CI: 1.59-9.80, P  = 0.003), and co-exist-
ing underlying adenoma (OR 2.66, 95% CI: 1.43-4.95, 
P  = 0.002).
CONCLUSION: �SI-H EGC is associated with unique 
endoscopic and clinicopathologic characteristics includ-
ing frequent presentation in protruded type, co-exist-
ing underlying adenoma, and synchronous lesions.
© 2012 Baishideng. All rights reserved.
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INTRODUCTION
Microsatellites are simple repetitive DNA sequences that 
are scattered throughout the genome. Instability within 
these sequences is a marker of  DNA mismatch repair 
deficiency[1]. The molecular mechanism of  high microsat-
ellite instability is the accumulation of  frameshift muta-
tions in the genes containing microsatellites within coding 
regions[2]. The resulting inactivation of  these target genes 
is believed to contribute to tumor development and pro-
gression. 
Previous research has focused on the analysis of  micro-
satellite instability (MSI) in various cancers[3-5]. In colorec-
tal cancer, high MSI (MSI-H) phenotypes are found in 
most cases of  hereditary nonpolyposis colorectal cancers 
and in 15% to 20% of  sporadic colon cancers[6]. The 
clinicopathologic characteristics of  MSI-H colorectal 
cancers are younger age, lower incidence of  lymph node 
metastasis, proximal location, and better survival rate[7,8].
In gastric cancer, the frequency of  MSI-H phenotype 
varies from 8.2% to 37%, depending on the number 
of  cases investigated and the definitions used[9,10]. The 
distinct features frequently reported for MSI-H gastric 
cancers include older age, antral location, intestinal type 
by Lauren classification, expanding type by Ming clas-
sification, and better survival[10-13]. However, studies with 
limited numbers of  patients have reported conflicting re-
sults regarding the association of  the MSI-H phenotype 
with better survival[14,15]. 
Since a limited number of  previous studies have dealt 
with endoscopic and pathologic findings of  early gastric 
cancer (EGC) according to MSI phenotype and most 
were focused on advanced gastric cancer (AGC)[10-13,16], 
we set out to analyze and clarify endoscopic and patho-
logic characteristics of  EGC according to MSI phenotype 
in this study.
MATERIALS AND METHODS
Patients and tissue samples
From December 2003 to October 2007, 981 patients un-
derwent radical total or subtotal gastrectomy and lymph 
node dissection for EGC, and the specimens of  all pa-
tients in this period were examined for MSI status. EGC 
was defined as gastric cancer limited to mucosa or sub-
mucosa, irrespective of  lymph node status[17]. Of  981 pa-
tients who were pathologically confirmed as having EGC, 
73 (7.4%) cases were categorized as MSI high EGC. For 
comparison, 146 non-MSI high EGC cases from the 
remaining 908 patients were consecutively selected as 
controls. Authorization for the use of  these tissues for 
research purposes was obtained from the Institutional 
Review Board of  Yonsei University College of  Medicine. 
Microsatellite analysis
Areas of  tumor and non-tumorous tissues on the slides 
were examined and marked under light microscopy. 
DNA was extracted from the uncovered hematoxylin and 
eosin-stained 6 µm-thick sections from formalin-fixed,    
paraffin-embedded tissues, using the QIAamp DNA 
Mini Kit (Qiagen, Hilden, Germany) according to the 
manufacturer’s instruction.
A panel of  five National Cancer Institute workshop-
recommended microsatellite markers (BAT25, BAT26, 
D2S123, D17S250 and D5S346) was used for analysis[18]. 
Polymerase chain reaction (PCR) was performed using 
a fluorescently labeled multiprimer, HotStar Taq poly-
merase (Qiagen) and the GeneAmp PCR system 2700 
(Applied Biosystems, Foster City, CA). The PCR condi-
tions comprised of  an initial cycle of  15 min at 95 ℃, 
followed by 30 cycles of  1 min at 94 ℃, 1 min at 57 ℃, 
and 1 min at 72 ℃. Amplification was completed with a 
final 5 min at 72 ℃. Automated ABI PRISM sequencer 
model 3100 Genetic Analyzer (Applied Biosystems) was 
used to analyze amplified PCR products according to the 
manufacturer’s instructions. 
MSI-H was classified as shift of  two or more mic-
rosatellite markers. Microsatellite instability at only one 
marker was classified as MSI-low (MSI-L). A case with 
no microsatellite instability was classified as microsatellite 
stable (MSS). The PCR results of  typical MSS and MSI-H 
cases are illustrated in Figure 1.
Analysis of endoscopic features
Two experienced endoscopists retrospectively reviewed 
the digital PACS images and the endoscopy database for 
all 219 cases. Most of  the upper endoscopies were per-
formed using GIF-Q260 or GIF-H260 (Olympus Opti-
cal, Tokyo, Japan), and a few cases were performed using 
GIF-Q240 in the early period of  2003. The endoscopic 
variables included in the analysis were the macroscopic 
classification of  EGC by the Japanese Gastric Cancer 
Association, which has been internationally accepted[19,20], 
location, color pattern and demarcation of  the tumor. 
Additionally, the endoscopic degree of  mucosal atrophy 
and intestinal metaplasia in the surrounding mucosa, and 
the presence of  synchronous neoplasm were also includ-
ed in the analysis. A synchronous lesion was defined as a 
distinctly separated lesion from the main EGC based on 
endoscopic findings. The endoscopic variables were com-
pared between the MSI-H and non-MSI-H EGC groups.
Analysis of clinicopathologic features
Clinical information, including age and sex, was obtained 
from medical records. The pathologic specimens of  all 
219 cases were reviewed again by an experienced gastro-
intestinal pathologist, and categorized as intestinal, dif-
fuse, or mixed according to the classification of  Lauren. 
The mixed type by Lauren classification was regarded 
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as intestinal type on analysis. The presence of  a muci-
nous component or a signet ring cell component were 
defined when these components exceeded 10% of  the 
tumor area. Lymphoid stromal reaction was categorized 
subjectively as absent, mild, moderate, or severe. Other 
pathologic variables for analysis included differentiation 
by World Health Organization (WHO) classification, 
invasion depth, lymphovascular invasion and co-existing 
underlying adenoma. 
Statistical analysis
The statistical analysis was performed using PASW ver-
sion 18.0. (SPSS Inc., Chicago, IL, United States). The       χ 2 
test was performed for comparison between the MSI-H 
and MSS/MSI-L groups in terms of  various clinicopath-
ologic parameters. The data for age and tumor size were 
analyzed by Student’s t-test. Each parameter was also as-
sessed by logistic regression. Differences were considered 
significant at P < 0.05. Estimated relative risks of  MSI-H 
with endoscopic and clinicopathologic factors of  EGC 
were expressed as odds ratios (OR) with corresponding 
95% confidence intervals (95% CI).
RESULTS
Clinical and endoscopic features of MSI-H EGCs
Of  981 EGC cases, 73 cases (7.4%) showed the MSI-H 
phenotype. The endoscopic features of  MSI-H EGCs are 
summarized in Table 1. MSI-H EGCs presented more 
frequently with elevated gross type (60.3% of  type Ⅰ or 
Ⅱa; P < 0.001), antral location (P < 0.001), moderate-to-
severe atrophy in the surrounding mucosa (P = 0.032), 
and presence of  a synchronous lesion (P = 0.018) than 
non-MSI-H EGCs. The typical endoscopic findings of  
MSI-H EGC are illustrated in Figure 2.
The color pattern and demarcation of  the tumor, 
and the degree of  intestinal metaplasia in the surround-
ing mucosa, were not significantly different between the 
MSI-H EGC and non-MSI-H EGC groups.
Clinicopathologic features of MSI-H EGCs
The clinicopathologic features of  MSI-H EGCs are sum-
marized in Table 2. In comparison to non-MSI-H EGCs, 
MSI-H EGCs were characterized by more frequent female 
sex (P = 0.001), older age (P < 0.001), better differentia-
tion by WHO classification (P = 0.003), intestinal type by 
Lauren classification (P = 0.017), presence of  a mucinous 
component (P = 0.017), absence of  a signet ring cell 
component (P = 0.041), moderate-to-severe lymphoid 
stromal reaction (P = 0.002) and co-existing underlying 
adenoma (P = 0.001). There was no significant difference 
between the MSI-H EGC and non-MSI-H EGC groups 
in terms of  tumor size, depth of  invasion, lymphovas-
cular invasion, and lymph node metastasis. The endo-
scopically identified synchronous lesions of  the MSI-H 
EGCs were diagnosed pathologically as EGC in 9.6% 
and adenoma in 9.6%. Synchronous lesions (P = 0.018) 
were significantly more frequent in the MSI-H EGC 
group when cases of  EGC and adenoma were combined. 
However, this difference lost its significance when syn-
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Figure 1  Polymerase chain reaction results of microsatellite analysis markers. A: Typical case of microsatellite stable early gastric cancer with no frameshift 
mutation; B: Typical case of high microsatellite instability showing frameshift mutations at 4 markers (BAT26, D5S346, BAT25 and D2S123, indicated as arrow).
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chronous EGC (P = 0.110) or adenoma (P = 0.163) were 
compared separately. 
Correlation between MSI-H and endoscopic and 
clinicopathologic features of EGCs
We analyzed the interrelationship between MSI-H pheno-
type and other endoscopic and clinicopathologic factors 
of  EGC by logistic regression analysis (Table 3). Upon 
logistic regression analysis, MSI-H EGC was significantly 
associated with elevated gross type (OR 4.38, 95% CI: 
2.40-8.01, P < 0.001), antral location (OR 3.99, 95% CI: 
2.12-7.52, P < 0.001), moderate-to-severe atrophy of  
the surrounding mucosa (OR 1.91, 95% CI: 1.05-3.47, P 
= 0.033), female sex (OR 2.77, 95% CI: 1.53-4.99, P < 
0.001), older age (> 70 years) (OR 3.30, 95% CI: 1.57-6.92, 
P = 0.002), a synchronous lesion (OR 2.65, 95% CI: 
1.16-6.07, P = 0.021), better histologic differentiation 
(OR 2.35, 95% CI: 1.27-4.34, P = 0.007), intestinal type 
by Lauren classification (OR 2.34, 95% CI: 1.15-4.76, 
P = 0.019), less signet ring cell component (OR 2.44, 
95% CI: 1.02-5.86, P = 0.046), presence of  a mucinous 
Figure 2  Typical endoscopic findings of microsatellite instability mutation early gastric cancer. Typical endoscopic features of high microsatellite instability 
early gastric cancers, which are grossly protruded type, arising from co-existing underlying adenoma, at an antral location. 
Table 1  Comparison of endoscopic features between the high 
microsatellite instability and non-high microsatellite instability 
early gastric cancer groups  n  (%)
Endoscopic findings MSI-H EGC 
(n  = 73)
Non-MSI-H EGC
(n  = 146)
P  
value
Main gross type  < 0.001
   Type Ⅰ 21 (28.8) 16 (11.0)
   Type Ⅱa 23 (31.5) 22 (15.1)
   Type Ⅱb 13 (17.8) 48 (32.9)
   Type Ⅱc   9 (12.3) 51 (34.9)
   Type Ⅲ 7 (9.6) 9 (6.2)
Location  < 0.001
   Antrum 56 (76.7) 66 (45.2)
   Body 15 (20.5) 77 (52.7)
   Cardia 2 (2.7) 3 (2.1)
Color 0.117
   Whitish color 2 (2.7) 9 (6.2)
   Normal mucosal color 27 (37.0) 36 (24.7)
   Erythematous color 44 (60.3) 101 (69.2)
Demarcation 0.265
   Definite 45 (61.6)       101 (69.2)
   Obscure 28 (38.4) 45 (30.8)
Intestinal metaplasia 0.138
   Absent-to-mild 41 (56.2) 97 (66.4)
   Moderate-to-severe 32 (43.8) 49 (33.6)
Mucosal atrophy 0.032
   Absent-to-mild 22 (30.1) 66 (45.2)
   Moderate-to-severe 51 (69.9) 80 (54.8)
Synchronous lesion 14 (19.2)         12 (8.2) 0.018
MSI-H: High microsatellite instability; EGC: Early gastric cancer.
MSI-H
EGC
(n  = 73)
Non-MSI-H 
EGC 
(n  = 146)
P  
value
Patients characteristics
Sex 0.001
   Male 37 (50.7)  108 (74.0)
   Female 36 (49.3) 38 (26.0)
Age (yr) 63.4 ± 10.4 56.8 ± 11.1 < 0.001
Pathologic findings
Size (mm) 22.4 ± 15.7 26.5 ± 13.0 0.055
Depth of invasion
   Mucosa 27 (37.0) 71 (48.6) 0.102
   Submucosa 46 (63.0) 75 (51.4)
Histologic differentiation 0.003
(by WHO classification)
   Well differentiated tubular 24 (32.9) 32 (21.9)
   Moderately differentiated tubular 30 (41.1) 48 (32.9)
   Poorly differentiated tubular 6 (8.2) 29 (19.9)
   Signet ring cell 8 (11.0) 43 (24.0)
   Mucinous 5 (6.8) 2 (1.4)
Lauren classification 0.017
   Intestinal 61 (83.6)  100 (68.5)
   Diffuse 12 (16.4) 46 (31.5)
Mucinous component 7 (9.6) 3 (2.1) 0.017
No signet ring cell component 60 (90.4)  116 (79.5) 0.041
Co-existing underlying adenoma 29 (39.7) 29 (19.9) 0.002
Lymphovascular invasion 17 (23.3) 22 (15.1) 0.134
Lymph node metastasis 12 (16.4) 14 (9.6)   0.14
Lymphoid stromal reaction 0.002
   Absent-to-mild 49 (74.2) 91 (91.9)
   Moderate-to-severe 17 (25.8) 8 (8.1)
Synchronous lesion   0.018
   Early gastric cancer 7 (9.6) 5 (4.8)   0.11
   Adenoma 7 (9.6) 7 (3.4) 0.163
Table 2  Comparison of clinicopathologic findings between 
the high microsatellite instability and non-high microsatellite 
instability early gastric cancer groups  n  (%)
MSI-H: High microsatellite instability; EGC: Early gastric cancer; WHO: 
World Health Organization.
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component (OR 5.06, 95% CI: 1.27-20.17, P = 0.022), 
moderate-to-severe lymphoid stromal reaction (OR 3.95, 
95% CI: 1.59-9.80, P = 0.003), and co-existing underlying 
adenoma (OR 2.66, 95% CI: 1.43-4.95, P = 0.002).
DISCUSSION
Although the worldwide incidence of  gastric cancer has 
been declining steadily, it remains the fourth most com-
mon cancer and the second most common cause of  
cancer death worldwide[21]. Despite identification of  nu-
merous genetic alterations in gastric cancers, their roles in 
tumorigenesis remain unclear. Across the gastrointestinal 
tract, the role of  MSI-H tumor has been studied more 
often in colorectal cancer than in gastric cancer, and MSI 
is one of  the clinically significant prognostic factors that 
is recommended for collection in the 2010 tumor, node, 
metastasis staging criteria for colorectal cancer[22,23]. On 
the other hand, there is no definite consensus about the 
role of  MSI-H in gastric cancer, and up to now, the ma-
jority of  MSI-H gastric cancer studies have focused on 
AGC and its prognosis. However, the clinicopathologic 
features and therapeutic approaches, such as endoscopic 
submucosal dissection, for EGCs are different from those 
for AGCs. In the present study, we focused on endoscop-
ic and clinicopathologic features of  MSI-H phenotype in 
EGCs. 
Our results revealed that EGC with MSI-H exhibits 
distinct clinicopathologic features, including distribu-
tion of  older age and female sex, antral tumor location, 
elevated gross morphology, better histologic differentia-
tion, intestinal type by Lauren classification, absence of  
a signet cell component, presence of  a mucinous com-
ponent, moderate-to-severe lymphoid stromal reaction, 
co-existing underlying adenoma, and more synchronous 
lesions including EGC and adenoma. Among the endo-
scopic features, the correlation between MSI-H and el-
evated gross morphology was a significant novel finding. 
It is reasonable to suspect that elevated gross type 
of  MSI-H EGCs could be explained by cancer progres-
sion from co-existing underlying adenoma. And if  we 
take into account the adenoma-carcinoma sequence in 
carcinogenesis of  gastrointestinal tract cancers, our data 
indicate that MSI-H EGC could more frequently origi-
nate from the co-existing underlying adenoma than non-
MSI-H EGC. As a consequence, EGC characterized by 
elevated mass might be preceded by transformation of  
co-existing underlying adenoma. 
A high MSI level has been shown to play an impor-
tant role in the development of  multiple carcinomas in 
colorectal cancer[24,25]. Several previous studies, which did 
not distinguish between AGC and EGC, have also shown 
that multiple synchronous gastric cancer is frequently as-
sociated with MSI-H[26,27]. In the present study, MSI-H 
EGCs were more often associated with synchronous epi-
thelial neoplasm including EGC and adenoma than non-
MSI-H, although the difference was not significant when 
the definition of  synchronous lesion was limited to car-
cinoma, but this may be due to small sample size in each 
group. Nevertheless, our data indicate that clinicians must 
consider the potential for synchronous lesions including 
adenomas and carcinomas in cases of  EGC with a con-
firmed MSI-H phenotype. 
In our analysis, MSI-H EGCs were more frequently 
associated with co-existing underlying adenoma than 
non-MSI-H EGCs, and had a tendency to have synchro-
nous adenoma. Given this association between MSI-H 
phenotype and adenoma, we cautiously propose that MSI 
impacts tumorigenesis at an earlier phase than dysplasia. 
This hypothesis is supported by results from previous 
studies revealing that MSI might play an important role 
in the early events of  progression from metaplasia or 
dysplasia to precancerous lesions, and then to gastric can-
cer[28,29]. Although there are a limited number of  studies 
on the significance of  the main 5 MSI mutations in EGC, 
a retrospective study from a high risk area of  gastric can-
cer in Italy showed that MSI is part of  the spectrum of  
genetic alterations in gastric non-invasive neoplasia[30].
Our study was limited by the fact that we only includ-
ed cases of  EGC treated with surgery, which may serve as 
a bias. We excluded patients with EGCs who underwent 
endoscopic resection due to uncertainty of  lymph node 
metastasis. Therefore, careful interpretation of  our results 
is needed to avoid bias and additional data from other 
studies that include all EGCs are required to validate our 
findings. Also, since this is a retrospective study and there 
are no actual data to support the temporal relationship 
between adenoma and progression into EGC, specula-
tion that EGC originated from underlying adenoma may 
Table 3  Logistic regression analysis of endoscopic and clini-
copathologic features of high microsatellite instability early 
gastric cancer
OR 95% CI P  value
Lower Upper
Endoscopic factors
   Elevated gross type (Ⅰ or Ⅱa) 4.38 2.40 8.01 < 0.001
   Antral location 3.99 2.12 7.52 < 0.001
Intestinal metaplasia 
(moderate-to-severe)
1.55 0.87 2.75 0.139
Mucosal atrophy 
(moderate-to-severe)
1.91 1.05 3.47 0.033
Clinicopathologic factors
   Female sex 2.77 1.53 4.99 < 0.001
   Age ≥ 70 years 3.30 1.57 6.92 0.002
   Histologic differentiation 
   (well or moderately)
2.35 1.27 4.34 0.007
   Lauren classification 
   (intestinal type)
2.34 1.15 4.76 0.019
   Submucosal invasion 1.61 0.91 2.87 0.103
   Less signet ring cell component 2.44 1.02 5.86 0.046
   Mucinous component 5.06 1.27 20.17 0.022
Lymph node metastasis 1.86 0.81 4.25 0.144
Lymphovascular invasion 1.71 0.84 3.47 0.137
Lymphoid stromal reaction 
(moderate-to-severe)
3.95 1.59 9.80 0.003
Co-existing underlying adenoma 2.66 1.43 4.95 0.002
Synchronous EGC or adenoma 2.65 1.16 6.07 0.021
OR: Odds ratios; CI: Confidence intervals; EGC: Early gastric cancer.
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be overstretching. We used the term “co-existing underly-
ing adenoma” instead of  “origin in underlying adenoma” 
to cope with this limitation. 
In conclusion, this study found that MSI-H EGCs 
more frequently present as protruded (type Ⅰ or Ⅱa) type 
in comparison to non-MSI-H EGCs, which is a novel 
finding; this is likely related to frequent co-existing under-
lying gastric adenoma. MSI-H EGC was found to have 
specific clinicopathologic characteristics, including older 
age, female dominance, antral location, moderate-to-se-
vere atrophy of  the surrounding mucosa, better histolog-
ic differentiation, intestinal type by Lauren classification, 
presence of  mucinous component, absence of  a signet 
ring cell component, moderate-to-severe lymphoid stro-
mal reaction, underlying adenoma, and synchronous le-
sions. The finding of  more frequent synchronous lesions 
in MSI-H EGC warrants us to inspect the stomach more 
thoroughly for other synchronous adenoma or EGC. 
Altogether, these findings could be used to better serve 
our understanding of  tumorigenesis and progression in 
MSI-H EGC, and could be used to set up diagnostic and 
treatment strategies in EGC patients. 
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better histologic differentiation, intestinal type by Lauren classification, absence 
of a signet ring cell component, presence of mucinous component, moderate-
to-severe lymphoid stromal reaction, and co-existing underlying adenoma.
Applications
EGCs with MSI-H seem to originate from underlying adenoma, following an 
adenoma-carcinoma sequence. Furthermore, more synchronous lesions in 
MSI-H EGCs indicate that thorough inspection and shorter follow up period is 
needed for endoscopic surveillance after diagnosis of early gastric carcinoma 
with MSI-H.
Peer review
This study evaluates relationship of phenotypic characteristics (endoscopic and 
clinicopathologic) of EGC with MSI-H. Multivariate logistic regression analysis 
revealed that MSI-H EGCs more frequently presented with elevated pattern 
(type Ⅰ or Ⅱa), moderate-to-severe atrophy in the surrounding mucosa, antral 
location and synchronous lesions than non-MSI-H EGCs.
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